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Abstract. In this paper, we investigate whether augmented reality visualization 
techniques can empower older adults to explore and understand medication in-
formation in an effective and timely manner. Through a user-centered design pro-
cess involving older adults and health professionals we developed an interactive 
camera-projector system called MeViTa (Medication Visualization Table) that 
projects medication information surrounding medication boxes laid on a table. 
Six designs were iteratively developed. In total 26 older adults, with a mean age 
of 71 (±7), participated in the user studies. Although no time benefits were ob-
served, participants perceived MeViTa as an effective means to explore and un-
derstand medication information, and as more engaging than the traditional pa-
tient information leaflet. Furthermore, by visualizing medication information, our 
approach provides qualitative findings of the relative ease and difficulty for older 
adults to learn more about medication information. 
Keywords: Medication, Camera-Projector, Older Adults, User-Centered 
1 Introduction 
Research shows that health literacy - the degree to which people have the capacity to 
obtain, process, and understand health information - decreases with age [25]. This is 
problematic as a large part of the older population is dependent on medication. For 
example, in the United States, more than half of the older population of 65+ needs to 
take more than five medications per week [41]. Furthermore, accidental medication 
misuse is also more common with older adults [32]. This misuse is generally related to 
the fact that medication information can be cumbersome to understand [5]. The work 
that is presented in this paper attempts to use innovative technology to make it easier 
for older adults to process medication information. This is an exploratory study focused 
on the user experience of older adults interacting with our proposed solution. 
Several approaches have been proposed to help older adults with technology. Be-
sides typical app-based solutions, the HCI community has shown the potential of using 
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more tangible, interactive technologies to assist people with various deficits and disor-
ders [3,24,44]. In this paper, we extend this body of research with a proof-of-concept 
that augments older adults in their capability to understand personal medication 
schemes. Through a user-centered design process involving older adults and health do-
main professionals (two medical software experts, two legal experts, and two medical 
researchers) we developed an interactive camera-projector system called MeViTa 
(Medication Visualization Table). MeViTa makes users’ data visible through an aug-
mented reality data visualization and visualizes 1) possible interactions between medi-
cation, 2) the user’s personalized dosage regimen, and 3) the probability of side-effects. 
Users can explore, interpret and engage with diverse kinds of information by putting 
medication boxes on the table, as presented in Fig. 1. Note that our design tries to com-
plement existing systems, such as medication reminders [10], not to replace them. This 
raises the key question whether allowing older adults to interact with augmented reality 
visualization techniques empowers them to explore, understand, and recall medication 
information. 
 
Fig. 1. Interaction View of the Final Design. The medication boxes on the table are recognized 
and medication information is projected surrounding the boxes. 
    We make the following contributions: first, we present the design and implementa-
tion of an open-source camera-projector system that visualizes medication information 
around medication boxes on a table. Second, we present evaluation results of the per-
ceived usefulness with in total 26 older participants and we describe both weaknesses 
and benefits for the HCI community working with augmented tools for older persons. 
Finally, we discuss issues older persons can experience during evaluations with a cam-
era-projector system. 
2 Background and Related-Work 
To give insight into the challenges posed by medication intake, we provide a short 
background and briefly discuss the challenges people can experience with medication 
intake and the effects of medication misuse. We then position our work within related 
work on camera-projector systems and assistive technologies. 
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2.1 Medication Use 
Correctly taking medication involves of a multitude of tasks: getting the right prescrip-
tion, buying the medication, reading the leaflet1 and searching for possible interactions 
between medications, allergies, and even food. One of the problems with medication 
use is that people can find it difficult to understand the traditional leaflets [23,30]. Ac-
cording to Liu et al. [30] leaflets “are inappropriate for use by older adults to manage 
their medications effectively, which could adversely affect patient safety and adherence 
to drug therapy.” Furthermore, Ng et al. [33] found users often struggled to make sense 
of the provided data in its default form and suggest the use of pictograms. 
Another problem is medication adherence. People often forget, or refuse, to take 
their medication for distinct reasons [19]. For example, they have a false idea about the 
inner workings of medication and feel they are unhealthy and unnecessary [38]. Fur-
thermore, people are often interested [11] in, or overestimate [7], potential side-effects. 
For example, people who intensively sport, might not want to take a medication that 
has fatigue as a side-effect. However, a general practitioner (GP) might discourage peo-
ple to lookup side-effects in fear of the nocebo phenomenon [4]. 
MeViTa aims to empower users by providing transparent and open medication in-
formation. Interactive visualizations encourage people to interact with the data. It helps 
users explore medication information and make the data more meaningful as people 
may understand and become more interested in medication schemes in the context of 
their own lives [11]. A combination of augmented reality and information visualization 
information techniques may also help them to understand the rationale for taking their 
medication correctly by visualizing the (often small) chance of side-effects in an unam-
biguous matter. As such, it may support decision-making and adherence to medication. 
We elaborate on technologies to support medication use for older adults in the next 
section. 
2.2 Health Technologies that Support Older Adults 
Several HCI researchers have explored opportunities to use technology to support 
the older adults. Medication reminders/helpers are well known assistive technologies 
in the medical domain. While medication adherence is a problem for all age groups, 
research suggests it is more common among older adults [31]. It is shown that dosage 
simplification, counseling, reminders, follow-up, supervised self-monitoring, and feed-
back have the largest positive effect [34,27]. Medication apps represent a possible strat-
egy to assist non-adherent people [10]. However, older adults are sometimes digital 
immigrants [48] who might miss prior experience with mobile and other touch enabled 
devices or prefer not to use them. Another approach are sensor-augmented pillboxes 
which were developed for older adults [29] or Personal Health Applications [40]. 
In this paper, we target self-supporting older persons who want to take ownership 
of their medication. A pill box is sub-optimal as it does not show the rationale and is 
limited to the medication regime. The overall goal is to empower older adults to explore 
                                                          
1 also known as: patient information leaflet (PIL) or patient insert 
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and understand medication information to address the risks and challenges, such as ac-
cidental medication misuse [32], medication interactions [16] and compliance [21]. 
In our prior work [11], we initially proposed the use of camera-projector technolo-
gies as a collaborative tool for improving communication between a GP and a patient. 
In this paper, we focus on how such technologies might assist older persons with their 
medication intake. We designed, implemented and evaluated views that represent the 
interplay between medications, dosage regimen and side-effects. 
2.3 Camera-Projector Systems 
In this work, we use a stationary camera-projector system. We based our approach on 
the work of Gugenheimer et al. [15] who “envision a future where such devices [cam-
era-projector systems] will be sold in hardware stores. They could be available in dif-
ferent form factors, either as a replacement for light bulbs or a simple small box which 
can be placed in several ways inside the users’ environments to be able to blend into 
the household.” Evidence of this vision can already be seen in industrial projects. For 
example, IKEA’s kitchen concept 2025 [20] shows an example of an augmented 
kitchen table. ActiveCues developed a similar system for people with dementia. Results 
from their initial studies are promising: “we saw an increase of positive emotions and 
social activity and a significant increase in their physical activity.” [1] Such systems 
can also be used to augment medication information. 
The research community has also been exploring the topic. LightSpace [49] for in-
stance explores a variety of interactions between camera-projector surfaces and 
metaDESK [46] is an important example of interaction techniques using a tangible user 
interface. Other applications can be devised for this technology. As Jones et al. [22] 
mentioned, “[m]any new and exciting possibilities remain to be explored.” By enabling 
the projection of interactive visualizations around medication boxes these systems can 
also be used to augment medication information, and this is in line with our requirement 
of empowering older persons with actionable knowledge about their medication. 
3 Design of MeViTa 
A main consideration for the design of MeViTa was the selection of the displayed in-
formation. In this section, we give an overview of the final design of MeViTa, shown 
in Fig. 1, and its technical details. The rationale and major design decisions are pre-
sented in Section 4. 
3.1 Visualizations 
The Final Design evolved through five intermediate designs as described in Section 4. 
Finally, as a result from this design process three different views remained to display 
relevant information to users: first, the Interaction View (Fig. 1) represents medication 
interactions, medication-induced allergies and warnings like alcohol and pregnancy. 
Second, the Dosage Regimen View (Fig. 2) depicts dosage schemes. Finally, the 
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Side-Effects View (Fig. 3) shows potential side-effects. To switch between these views, 
users should move all the boxes on the table to specific areas of the projected interface. 
No touch interface elements were added to prevent older users from unintentionally 
activating a function [17]. Thus, only by using tangible objects on the table, users can 
switch between views. 
To start using MeViTa, users are required to put all their medication boxes on the 
table. The system then recognizes these boxes and displays the Interaction View. Red 
to green colored circles surrounding the boxes indicate whether users can take the med-
ication, or how long they should wait until it is safe to take the medication again. The 
rationale for taking each medication is described at the bottom of the table (headache/in-
somnia/etc.). Allergies are listed at the table’s top right corner. Warnings are repre-
sented as icons around the boxes’ surrounding circles. Grey dotted lines are drawn be-
tween the medication boxes and their respective rationales. Red lines connecting two 
boxes represent potential medication interactions. Finally, orange dotted lines connect-
ing boxes with allergies or warning icons represent risk associations to alcohol, preg-
nancy, breast-feeding, driving, and food (e.g. grapefruit). For example, in Fig. 1 the 
upper left box shows a warning for alcohol consumption. 
To access the Dosage Regimen View, users should put the boxes in a designated area 
on the left side of the table. This view uses a table layout and is a personalized medica-
tion scheme based on the system used in the national health platform [47]. It displays 
the number of pills and the times of each dose. 
Finally, to see the Side-Effects View, users should put the boxes in the lower desig-
nated region of the table. This view also uses a table layout, projecting the list of all 
known side-effects on the table’s first column and the association (probability) that each 
medication has with each side-effect on the remaining columns. These probabilities are 
projected above each medication using icon displays: blue-colored icons represent the 
likelihood of each side-effect. 
3.2 Technical Design 
The visualizations are implemented using the D3.js (4.2.1) [8] JavaScript library, in 
combination with Underscore (1.8.3) for data calculations, and SAT.js (0.6.0) for col-
lision detection. Both the patient record and medication information is stored in JSON 
files. The recognition of medication boxes is done using a slightly modified version of 
Labbé’s find-object (0.6.0) tool [28], which uses OpenCV (3.1). The Speeded Up Ro-
bust Features (SURF) [6] algorithm is used for keypoint detection and description. It 
took the system approximately 0.2s per medication box to determine the location in the 
scene. The visualization itself updated every 0.5s to adapt for changed locations within 
trial-and-error determined thresholds. 
MeViTa consists of a standard webcam, i.e. Logitech c930e camera, with a 
1920x1080 resolution and a 90 degrees’ field, a short throw Acer H6517ST projector 
with a 1920x1080 resolution and 3000lm, and a MacBookPro12.1, which is a standard 
setup for a camera-projector system [51]. Since the essential part of the information is 
projected around the medication boxes, the system is mounted on the ceiling with both 
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the projector and the camera pointing down towards the table. Calibration is done man-
ually for each new location by registering the outer areas of the field of view. More 
sophisticated calibration is possible, but would go beyond the scope of this work. No 




Fig. 2. Dosage Regimen View, this view is shown when all boxes are put on the left side of the 
table. For example, the user should orally take 3 pills during breakfast, and 1 during lunch of 
Strepfen. 
 
Fig. 3. Side-Effects View, this view is shown when all boxes are put on the bottom. For example, 
in this fictive scenario Strepfen has a very high chance (60%) of headache and a 30% chance of 
causing high blood pressure. Percentages are not displayed in number but by coloring human 
figures proportionally. 
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4 Iterative User-Centered Design Process 
To design the visualizations, a user-centered methodology was applied to gradually im-
prove the initial design of the visualizations. After every evaluation, qualitative feed-
back was addressed in the next design, which was then again evaluated. Participation 
was voluntary and not compensated. Furthermore, each participant could only partici-
pate once. An overview of the different studies is presented in Fig. 4. 
 
 
Fig. 4. Timeline that shows the studies and the participants in each iteration. Keywords from the 
most important problems identified in each intermediate study are numbered in bold. The design 
used in each study is shown on the arrows. 
4.1 Study 1: Concept 
The Initial Design of MeViTa is inspired by prior research on medication visualizations 
[12] and barriers of communicating health information [36]. It was designed in Power-
Point. Guidelines from the Visualizing Health [45] project were also considered. Their 
summary table, for example, is “suitable for use in decision aids or medication pack-
aging.” This initial design was discussed with a consortium of health domain profes-
sionals, including two medical software experts, two legal experts, and two medical 
researchers. The role of the legal experts was to validate compliance with the General 
Data Protection Regulation (GDPR) (Regulation (EU) 2016/679). 
All consortium members attended a presentation introducing the topic of disclosing 
medication information to older adults using a camera projector system before the Ini-
tial Design was shown. The design primarily served as an exploration of the domain 
and formed the basis for Low-Fidelity Design 1. Two major attention points were 
raised: Problem 1) the overview was too crowded: too much information was displayed 
at once which can be confusing to older adults since the ability to suppress irrelevant 
representations or response tendencies is known to degrade with age [18]; and Problem 
2) absolute percentages to visualize changes of side-effects are hard to grasp [13]. 
4.2 Study 2: Usability 
The Initial Design helped to design the Low-Fidelity Design 1 as shown in Fig. 5. The 
information was divided into four different projections to address Problem 1: 
1. interactions and reasons  (Fig. 5A)   →   Interaction View, 
2. dosage regimen  (Fig. 5B)   →   Dosage Regimen View, 
3. side-effects   (Fig. 5C)   →   Side-Effects View,  
4. schedule   (Fig. 5D)   →   Schedule View. 
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The circles were not used for the dosage regimen anymore and were now used to 
visualize the half-life, which is the time the medication remains in the blood. Further-
more, the side-effects were now visualized based on [43] instead of percentages (Prob-
lem 2). Users could switch between modes by putting their medication boxes in a re-
spective region. To make this design more realistic, it was developed in PowerPoint so 
that it could be projected on a table during the expert user evaluation. Five HCI experts 
were asked to perform a list of typical user tasks to expose usability issues. Two key 
issues were exposed: Problem 3) all information in the schedule was redundantly vis-
ualized in the Dosage Regimen View (3/5), and Problem 4) it is cognitively hard to 
remember the four regions to put medication (4/5). 
4.3 Study 3: Medical Validity 
An attempt was made to solve these issues in Low-Fidelity Design 2. The Sched-
ule View was removed (Problem 3), thus there are only three main regions to put the 
medication boxes (Problem 4). This updated design was evaluated with an expert GP 
from the academic center for general practice to test medical relevance. Two problems 
were identified: Problem 5) the thickness of an interaction line showed the severity, 
and an orange-to-red hue indicated the probability of a possible interaction. However, 
this information is often not available in real patient records; and Problem 6) the se-
verity of a side-effect is a very personal experience and an impersonal, independently 
determined severity level is thus best not shown. 
 
 
Fig. 5. Overview of the Low-Fidelity Design 1. The view projected depends on the location of 
the boxes. When they are divided over the table the user sees the (A) Interaction View; when they 
are on the left side the (B) Dosage Regimen View, at the top the (C) Side-Effects View, and on 
the right side the (D) Schedule View. 
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4.4 Study 4: Explorative Evaluation with Older Adults 
Based on previous feedback a fully working High Fidelity Design was built as pre-
sented in Fig. 6. To cope with earlier remarks, we only showed one type of connection 
between medications from the start (Problem 5): once there was the chance of an inter-
action a line was drawn between the two medications, hence the severity, and probabil-
ity were not shown. Furthermore, the severity of side-effects was not shown (Problem 
6), only the occurrence. 
This intermediate study consisted of four parts: 1) an initial questionnaire exploring 
demographics and existing attitudes towards medication intake; 2) a task-based sce-
nario; 3) a perceived usefulness questionnaire based on [35] complemented with addi-
tional questions; and finally 4) the System Usability Scale (SUS) [9]. Participants were 
recruited through a paper invitation distributed amongst people at a local older adults’ 
community. Eleven older persons (74 ± 8.3, 5 females) participated in this study. One 
participant did not take any medication, four participants needed to take only one pill a 
day and the six others took 3 to 10 pills per day. Three received help from their partner 
and two received a letter from their GP to prepare a pill box. MeViTa was installed in 
the home of one participant as the community was a far distance from the research 
center and it was impossible for some participants to travel the distance. The other par-
ticipants were invited to this participant’s home. Thus, the evaluation happened in a 
real home as shown in Fig. 6. 
 
 
Fig. 6. This video’s screenshot shows the Interaction View and a participant (left) who is asked 
by the facilitator (right) to perform a certain task. Four medications are put on the table. Note the 
blue circles visualizing the half-life, which were replaced by the red to green circles in the latest 
design due to the deemed complexity. 
Comparison with the Leaflet. To enable a comparison between MeViTa and the 
leaflet, participants were initially asked to answer five questions using the leaflet. How-
ever, we did not complete this part of the study as five participants did not want to read 
the leaflet (Problem 7) because their doctor, who might consider the nocebo phenom-
enon [4], advised them to not read leaflets. Moreover, two participants mentioned their 
partner read it. Three other participants could either not find (2/11) or read (1/11) the 
information. Hence, only 1 out of 11 participants could successfully read the traditional 
leaflet. 
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Task-Based Scenario. During the task-based scenario participants were asked to 
answer seven questions. All participants had to answer the same questions on the med-
ication scheme which was based on a real medication scheme. This scheme contained 
of four medications and served as a simple use case of medication intake. However, it 
was discussed at the Academic Center for General Practice in Leuven to represent a 
realistic use case. To avoid that participants could answer questions from memory and 
not look at the table to complete their task, fictional medication boxes were used with 
altered medication names. Unfortunately, most participants were confused by the med-
ication they did not recognize (Problem 8). For example, when asked to answer why 
Cymbolto was used two participants said without looking at the table: “I don’t know, I 
don’t take this medication.” In total five out of 11 participants did not look at the table 
and immediately indicated they did not know the answer. Similar observations were 
made during the other tasks. 
The question about the medication’s half-life did not interest our participants (Prob-
lem 9). A participant summarized it perfectly: “I don’t care; my doctor should know 
this.” It is interesting to note that although participants were told that they could touch 
and move medication boxes on the table, none of the participants touched the boxes, 
unless explicitly asked to do so. However, when they needed to move the boxes to 
switch views we observed some difficulties reaching the upper part of the table (Prob-
lem 10). 
Perceived Usefulness and System Usability. The fact that participants were con-
fused between the real medication and the imaginary medication that had some letters 
changed (Problem 8) was also clear in the average SUS score of 64, which is below the 
average score of 68 [2]. Participants responded neutral when asked whether they felt 
confident using the system. Answers on the perceived usefulness questionnaire are 
shown in Fig. 7. Notwithstanding the difficulties with the name confusion, the whiskers 
show both the mean and median range above neutral. 
 
 
Fig. 7. Answers from the 11 participants ranging from strongly disagree to strongly agree. The 
boxes visualize the answers on the perceived usefulness questions. Dotted lines indicate the mean 
and standard deviations. 
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4.5 Study 5: Evaluation Setup Validation 
Before conducting the final user study, the updated design setup was evaluated in a 
short intermediate study. To address Problem 9, the circles visualizing the medication’s 
half-life were replaced by simpler circles that show whether it is OK to take the medi-
cation. Furthermore, to enhance reachability (Problem 10) the area for side-effects was 
moved to the bottom of the table. This time, participants received a 1-minute demon-
stration of MeViTa using a box of iron staples to show that the meaning of the boxes 
was not important. We deliberately chose not to show a legend to evaluate whether the 
visualizations were clear without it. In contrast to Study 4: Elderly Community (Section 
4.4), it was strongly emphasized they were not looking at their own medication but at 
the medication scheme of Julie Janssens, a fictive woman of 73 years old weighing 76 
kg. Furthermore, only the colors of the boxes were mentioned by the main researcher 
to address Problem 8. 
We tested this High-Fidelity Design 2 with three participants that were initially re-
cruited for the final evaluation (Section 5). Only one minor usability issue was discov-
ered and optimized in the Final Design: a grey area was added to the bottom to indicate 
more clearly the area for side-effects. Another grey area was added on the left of the 
table to indicate the area for the medicine schedule. 
5 Final Evaluation 
This section describes the final user evaluation of the Final Design resulting from the 
five prior studies as described in Section 4. This evaluation explores whether allowing 
older adults to interact with augmented reality visualization techniques empowers them 
to explore, understand, and recall medication information in an effective and timely 
manner. 
5.1 Participants 
Participants were found using a call for participation published in a major health insur-
ance members’ magazine. We did not impose an age limit and all self-identified seniors 
could participate. These self-supporting older adults are the actual target group of 
MeViTa. In total, 45 people responded to the call and were contacted by the main re-
searcher explaining the research and planned evaluation in more detail. Each participant 
was asked to attend an evaluation session of maximum one hour at the nursing home or 
at the university’s computer science department. A mileage allowance was offered in 
return. In total 22 participants were willing and able to attend an evaluation session, of 
which seven canceled last minute due to personal reasons. The first three participants 
were used to validate the updated evaluation setup (Section 4.5). Hence, in total 12 
older adults (3 females) participated in the final evaluation. They were on average 67.5 
(± 5.5) years old and took on average 9 (± 5.5) pills every day. 
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5.2 Experimental Setup and Measurements 
At the start, each participant received an information sheet and was asked to sign an 
informed consent. Like Studies 4 and 5 the evaluation started with an initial demo-
graphic questionnaire. After a tutorial, similar to Study 5: Evaluation Setup Validation 
(Section 4.5), participants were asked 1) to find two side-effects, and 2) the dosage 
regimen of Motilium using a leaflet. Next, using MeViTa, the same two tasks and five 
additional tasks were asked in random order. The same approach as in Study 5: Evalu-
ation Setup Validation was applied. It was emphasized they were not looking at their 
own medication but at the medication scheme of a fictive woman. Participants were 
asked to think aloud. The following parameters were measured: 
─ Time. How much time does a participant need to complete a given task from the 
scenario? These timings are extracted from the recorded video files and compared 
to the time needed to find information in a traditional leaflet. 
─ Interaction strategies. Based on the recordings each interaction performed was 
logged and analyzed to detect potential strategies participants applied. 
─ Memorability. We wanted to learn if participants recalled more information when 
they visually saw the information instead of reading the information from leaflets. 
Participants were asked to recall information from two tasks they performed using 
both the leaflet and MeViTa. 
After this task-based scenario seven perceived usefulness questions based on O’Leary 
et al. [35] and ten SUS [9] questions were asked. 
5.3 Traditional leaflet and Task-Based Scenario 
Table 1 provides an overview of each task and the average completion time. To avoid 
the pitfalls of Study 4: Elderly Community (Problem 7), participants were asked to 
perform only two tasks using the leaflet. To account for GPs’ nocebo phenomenon con-
cerns [4] the leaflet of an off-the-market medication Motilium was provided. 
Task 1) “Can you tell me the side-effects of Motilium” or for MeViTa “Can you tell 
me the side-effects of the white/red box?” was successfully completed by nine out of 12 
participants using the leaflet (69s±37s). However, three participants were not able to 
list the side-effects. To solve this task using MeViTa, participants had to move all boxes 
on the table to the bottom to switch to the Side-Effects View. Compared to the leaflet, it 
took participants longer to answer the question (107s±55s) because they initially moved 
just one box. On the other hand, all participants could successfully find all side-effects. 
Task 2) “On which times during the day can Julie use Motilium” and “On which 
times during the day can Julie use the red box” was answered correctly by all 12 par-
ticipants both by using the leaflet (29s±19s) and by using MeViTa (45s±33s). With 
MeViTa, participants first had to move all boxes to the left side of the table to switch 
to the Dosage Regimen View. Then a table with the dosage regimen is projected on the 
table. Each row is the regimen for the corresponding medication. In contrast to the prior 
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task, only four participants initially moved only one box. This indicated they remem-
bered how to switch modes using the boxes: “Then I have to get to that other screen for 
sure?” 
To alleviate potential resistance to reading the leaflet, participants were asked only 
two questions using the leaflet. Therefore, the following tasks were only performed 
using MeViTa. Task 3) “Why do you think Julie should take this blue box?” could easily 
be solved using the Interaction View. A grey dotted line connected the blue box with 
‘fibromyalgia’. This task was completed swiftly (5s±2s) and correctly by all 12 partic-
ipants. 
Task 4) “How do you rate the chance Julie will get a dry throat?” could be solved 
by moving all boxes to the bottom of the table and thus switch to the Side-Effects View. 
There, a medication’s side-effects are shown in a column above the medication box 
(see Fig. 3). As the tasks were given in random order, some participants already started 
from the Side-Effects View while others first needed to move all boxes. However, all 
12 participants completed the task correctly 10s±10s. Interestingly, participants rated 
the likelihood of side-effects lower than prescribed in the leaflet. When there were ten 
or less out of hundred person icons colored, participants rated the likelihood as uncom-
mon, while the leaflet would list them as common. 
Task 5) “Do you think Julie can drink alcohol while taking these medications?” 
could be solved using the Interaction View. As shown in Fig. 1 orange dotted lines are 
drawn from the medication box to an alcohol symbol when an interaction is possible. 
However, this task created confusion with our participants as they were always taught 
not to drink any alcohol when on medication: “Of course, I assume that you do not 
drink alcohol, that is obvious.” Five participants therefore first moved all boxes to the 
bottom of the table to spot the side-effects, which also weights on the average time 
(20s±21s). 
Task 6) “Can Julie combine these two blue boxes” could be solved using the Inter-
action View. One of the primary features of the Interaction View is the opportunity to 
check for medication-medication interactions. When two medications harmfully inter-
act with each other a red line is drawn between the two boxes. However, three out of 
12 participants switched to the Side-Effects View thinking that two similar side-effects 
might strengthen each other. Eventually, all 12 participants spotted the red line between 
two boxes and could finish this task successfully (53s±66s). Moreover, participants re-
membered to divide the boxes over the table for a better overview: “but you [I] should 
not put the boxes too close to each other.” 
Task 7) “How much longer before Julie can take a pain killer for her headache?” 
could be solved using two different approaches. The Interaction View shows a green 
circle surrounding a medication box when the user can take that medication now. Users 
can also use the Dosage Regimen View to see if enough time has passed since the last 
dose. Ten out of 12 participants completed the task (30s±27s): four participants used 
the Dosage Regimen View to complete this task, while six other participants used the 
Interaction View. Two participants were unable to complete this task: “How should I 
know this?” and “I don’t know, it depends on what the doctor says.” 
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Table 1. Average time needed to perform each task and the view needed. 
Task Leaflet MeViTa ∆ View 
1. Can you tell me the side-effects of that 
white/red box? 
69s±37s 107s±55s +70s Side-Effects 
2. On which times during the day can Julie 
use the red box? 
29s±19s 45s±33s +16s Dosage Regimen 
3. Why do you think Julie should take this 
blue box? 
/ 5s±2s / Interaction 
4. How do you rate the chance Julie will get 
a dry throat? 
/ 10s±10s / Side-Effects 
5. Do you think Julie can drink alcohol 
while taking these medications? 
/ 20s±21s / Interaction 
6. Can Julie combine these two blue 
boxes? 
/ 53s±66s / Interaction 
7. How much longer before Julie can take a 
pain killer for her headache? 
/ 30s±27s / Interaction or 
Dosage Regimen 
5.4 Results on the Perceived Usefulness and Usability Questionnaire 
As illustrated in Fig. 8, answers to Likert scale questions scored consistently high. 
When participants were asked whether MeViTa increased their comprehension of med-
ication schemes 10 out of 12 participants agreed. The two participants that were less 
positive argued they first needed to get acquainted with the system. All participants 
agreed that the design can create medication awareness. Ten participants answered they 
would like to use the system when they would need to talk to their GP. One participant 
who responded neutral indicated her doctor “is 82 years old, and doesn’t like comput-
ers.” The strongest benefit mentioned is that both the user and the GP would have the 
same overview which makes it is easier to signal a certain problem to their caregiver. 
Participants also liked the fact that a general overview of all their medication is gener-
ated. This could be particularly useful when they need to go a different specialist. Par-
ticipants agreed that there is a need for a system to interact with medication as “young 
caregivers need to search too much information, anciens [older, more experienced 
caregivers] already know all of that.” Participants agreed MeViTa is ‘a’ right kind of 
tool, yet seven participants responded neutral as it is not necessarily ‘the’ right kind of 
tool. Eight out of 12 participants strongly agreed and 4 agreed that the system can pre-
vent medical mistakes, such as for example medication-medication interactions. Fi-
nally, the details are at the right level for 11 out of 12 participants. The scores on the 
SUS questionnaire was on average 81.5, ranking MeViTa with an A grade [37]. The 
question on whether they would like to use the system frequently scored lowest. Two 
out of 12 participants who answered negatively mentioned they would only like to use 
it when they were prescribed new medication, or when they have a question. In contrast 
to prior evaluation, both questions: “I felt very confident using the system” and “I think 
that I would need the support of a technical person to be able to use this system.” scored 
positive suggesting an improvement over the previous setup. 
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Fig. 8. Answers from the 12 participants ranging from strongly disagree to strongly agree. The 
box plots visualize the answers on the perceived usefulness questions. Dotted lines indicate the 
mean and standard deviations. 
5.5 Interaction Strategies 
In Study 4: Elderly Community (Section 4.4) participants only touched the medication 
boxes when they explicitly needed to move them to alternate between views. In this 
evaluation, however, other interaction strategies were observed. We observed two kind 
of actions. The first kind of actions we call ‘better overview’: some participants moved 
the boxes in such a way to eliminate line intersections or moved boxes further apart to 
create more distance between the visualization elements for a better overview. The sec-
ond type of interactions we classify as ‘remove’: some participants took non-relevant 
boxes from the table to simplify the visualization. Initially, we also logged when par-
ticipants touched the boxes to confirm they were answering the questions of the right 
box and when they, unintentionally, held something above the boxes so the camera lost 
track of the box. All actions were logged using the video recordings and manually ex-
tracted. Table 2 shows a summary of all actions logged. 
No relation, nor trend was found between the amount of times a participant per-
formed an interaction and how he or she performed on a task. Nor was there any trend 
observed between the amount of interactions and the answers on the questionnaires. 
However, as explained above, two strategies were observed for obtaining a better over-
view: moving boxes or removing them. The latter strategy was mostly used when par-
ticipants needed to move boxes to switch between views. They moved the box they 
were interested in to the right location and took the other boxes away. Finally, the view 
from the camera was blocked seven times of which three occurrences are related to one 
participant. This was not an issue as this primarily occurred while participants were 
moving other boxes around so they did not even notice this occurrence. 
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Table 2. Overview of the number of times participants interacted with the medication boxes 
ranked per task. 
 
5.6 Memorability 
After each evaluation participants were asked 1) if they could still name the side-effects 
of Motilium and the side-effects of the white/red box, and 2) if they could say the dos-
age regimen of both Motilium and the red box. Question 1 and 2 were answered cor-
rectly by respectively five and eight participants who used the leaflet. 
Using MeViTa, correct responses were lower: question 1 and 2 were answered cor-
rectly by two and five participants respectively. From these results, we cannot show 
MeViTa helps participants recall medication information more effectively. 
6 Discussion 
6.1 MeViTa as a Tool to Explore Medication Information 
In this paper, we proposed MeViTa to empower older adults to explore medication 
information. MeViTa is designed using a user-centered methodology. Thus, changes 
made to each intermediate design improved general usability and functionality. Sug-
gestions raised during the five iterative studies were incorporated in each updated ver-
sion as described in Section 4. 
It is important to optimize and minimize the information shown to the user. On the 
other hand, Shneiderman’s mantra [39] advocates to first show an overview and after-
wards let the user find the details on demand. However, our initial design was deemed 
too complex by our expert consortium members (Problem 1). Furthermore, it showed 
redundant (Problem 3) or non-interesting information (Problem 9), such as the medica-
tion’s half-life, which could make it harder to remember how to switch between views 
(Problem 4). In Study 3: Medical Validity we learned which medication information is 
locally available (Problem 5) and that health-related issues are a personal experience 
(Problem 6). Finally, especially when working with an older audience, reachability 
should be considered (Problem 10), as they can experience issues reaching the far end 
of a table. 
Although none of our participants had interacted with a camera-projector system 
before, most remarks concerned the visualization’s learning curve and not the use of a 
camera-projector system. We thus argue that the technical choice was appropriate to 
test our visualizations. Alternative solutions include a tabletop that can recognize tan-
gibles or a tablet. All participants mentioned they liked this approach as they did not 
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need to learn any new interaction paradigms. The positive perception is also reflected 
in the average SUS score of 81.5. 
Finally, we observed that by showing the little colored people icons to show uncer-
tainty [43] people were generally less concerned with the likelihood of a side-effect. 
When they visually saw 1 in 100 people, they realized the likelihood is smaller than 
they initially thought when just reading 1% or ‘uncommon’. As our sample size is 
small, we cannot draw strong conclusions from this observation, but the observation is 
interesting for further research. 
6.2 Lessons Learned with Older Participants 
Important lessons were learned by analyzing the qualitative evaluation data and by ob-
serving our participants performing each task. Foremost, like Kobayashi et al. [26] our 
participants in Study 4: Elderly Community were easily confused. In the succeeding 
studies participants were therefore better informed about the medication on the table 
not being their own medication for evaluation purposes. Furthermore, the name of Julie 
was always mentioned as a reminder and colors were used to refer to medication. 
Like Wrede-Sach et al. [50], we also learned older adults place a lot of trust in their 
GP. Some participants were not willing to read an unknown leaflet as their doctor told 
them not to read their leaflets. Moreover, in Study 4: Elderly Community only one 
participant could successfully read the leaflet. Therefore, in the final evaluation, we 
only asked participants to do two tasks using the leaflet and used an off-the-market 
medication to consider their doctors’ concern. Even then, we could sometimes notice 
some frustration when they were asked a second question using the leaflet. Although 
we observed faster timings when participants were asked to perform a similar task, this 
chosen methodology limited us to ask the participant to perform similar tasks to elimi-
nate learning effects. 
6.3 Evaluation Results 
Answers on the perceived usefulness questions improved compared to Study 4: Elderly 
Community. Reasons can be twofold. First, both the issues with the non-interesting 
half-life and the reachability were addressed and consequently participants received a 
better experience. Second, the participants in the first iteration were on average seven 
years older and were recruited through a community, whereas participants in the final 
evaluation were recruited using a public call in a health magazine and were asked to 
register online. 
Only basic interaction strategies were discovered. Participants moved boxes for a 
better overview, took boxes from the table to simplify the visualization and sometimes 
touched the box to ask for confirmation. Given our limited number of participants, no 
statistically relevant results could be discovered. However, in contrast to Harada et al. 
[17], we did not discover any unintentional interactions by using objects as an input 
mechanism to control the views [14]. 
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6.4 Limitations 
The number of participants (in total 26) and the absence of a control condition can be 
seen as a limitation of our current work. However, like Sonne et al. [42] “we argue [...] 
that it is more important to first uncover potential problems and understand the use of 
the technology, than to conduct longer and larger efficacy studies.” Furthermore, to 
allow for a comparison between participants we used a non-personal realistic medica-
tion regimen instead of asking each participant to bring their own medication. Moreo-
ver, we should first discover potential issues and get medical clearance before showing 
real, personal medication information. 
7 Conclusion 
In this study, we made the following contributions: first, we presented the design and 
implementation of an open-source camera-projector system that visualizes medication 
information around medication boxes on a table. Second, we presented the results of 
the evaluation of the perceived usefulness of our design with in total 26 older adults 
participants, and we described both weaknesses and benefits for the HCI community 
working with technology for older adults. Finally, we also discussed the issues older 
adults can experience during evaluations with a camera-projector system. To further 
validate MeViTa, we already made a tentative agreement with the country’s largest 
medication database provider to use their medically validated data in MeViTa. 
We believe that with five intermediate studies as described in Section 4, and the final 
evaluation we could to show the perceived usefulness of MeViTa. Qualitative feedback 
gathered in the different studies shows that MeViTa can empower older adults by vis-
ualizing medication information. Although not everybody agreed MeViTa is the only 
kind of tool that could help them, they do strongly agree there is a need for an applica-
tion that helps them explore medication info. Unfortunately, we were not able to proof 
that MeViTa can augment people’s ability to recall medication information better or 
has a time benefit. However, participants indicated that MeViTa helps to understand 
medication information and increases awareness, that it helps to reduce medical errors 
and that they would like to use MeViTa in sessions with their GP. 
Acknowledgments 
MyHealthData is a project co-funded by imec, a digital research institute founded by 
the Flemish Government. Project partners are EBMPracticeNet, CEBAM, HealthCon-
nect, CM, and MindBytes with project support from Agentschap Innoveren & Onder-
nemen. The authors would also like to thank all participants and the anonymous re-
viewers for their extensive feedback to improve the quality of the paper. 
 MeViTa: Visualizations to Help Older Adults with their Medication 19 
References 
1. ActiveCues: Tovertafel original. https://dutchgamesassociation.nl/thoughts/ 517, accessed: 
2017-5-5 
2. Bangor, A., Kortum, P., Miller, J.: Determining what individual SUS scores mean: adding 
an adjective rating scale. Journal of Usability Studies 4(3), 114–123 (May 2009) 
3. Bardram, J.E., Frost, M., Szántó, K., Faurholt-Jepsen, M., Vinberg, M., Kessing, L.V.: De-
signing mobile health technology for bipolar disorder: a field trial of the monarca system. 
In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. pp. 
2627–2636. ACM, New York, New York, USA (Apr 2013) 
4. Barsky, A.J., Saintfort, R., Rogers, M.P., Borus, J.F.: Nonspecific medication side effects 
and the nocebo phenomenon. JAMA 287(5), 622–627 (Feb 2002) 
5. Basen, M.M.: The elderly and drugs– problem overview and program strategy. Public Health 
Rep. 92(1), 43–48 (1997) 
6. Bay, H., Ess, A., Tuytelaars, T., Van Gool, L.: Speeded-Up robust features (SURF). Comput. 
Vis. Image Underst. 110(3), 346–359 (Jun 2008) 
7. Berry, D.C., Knapp, P., Raynor, D.K.: Provision of information about drug sideeffects to 
patients. Lancet 359(9309), 853–854 (Mar 2002) 
8. Bostock, M., Ogievetsky, V., Heer, J.: D³: Data-Driven documents. IEEE Trans. Vis. Com-
put. Graph. 17(12), 2301–2309 (Dec 2011) 
9. Brooke, J.: SUS-A quick and dirty usability scale. Usability evaluation in industry 189(194), 
4–7 (1996) 
10. Dayer, L., Heldenbrand, S., Anderson, P., Gubbins, P.O., Martin, B.C.: Smartphone medi-
cation adherence apps: potential benefits to patients and providers. J. Am. Pharm. Assoc. 
53(2), 172–181 (Mar 2013) 
11. De Croon, R., Klerkx, J., Duval, E.: A Proof-of-Concept visualization to increase compre-
hension of personal medication schemes. In: Proceedings of the 10th EAI International Con-
ference on Pervasive Computing Technologies for Healthcare. pp. 25–32. ICST, Cancun, 
Mexico (Jun 2016) 
12. Duke, J., Faiola, A., Kharrazi, H.: A novel visualization tool for evaluating medication Side-
Effects in multi-drug regimens. In: Jacko, J.A. (ed.) HumanComputer Interaction. Interact-
ing in Various Application Domains, Lecture Notes in Computer Science, vol. 5613, pp. 
478–487. Springer Berlin Heidelberg, Berlin, Heidelberg (2009) 
13. Fischoff, B., Brewer, N., Downs, J.: Communicating risks and benfits: An evidencebased 
user’s guide. Tech. rep., Food and Drug Administration, New Hampshire Ave, Silver Spring 
(2011) 
14. Fitzmaurice, G.W.: Graspable user interfaces. Ph.D. thesis, University of Toronto (1996) 
15. Gugenheimer, J., Knierim, P., Winkler, C., Seifert, J., Rukzio, E.: UbiBeam: Exploring the 
interaction space for home deployed Projector-Camera systems. In: Abascal, J., Barbosa, S., 
Fetter, M., Gross, T., Palanque, P., Winckler, M. (eds.) Human-Computer Interaction – 
INTERACT 2015. vol. 9298, pp. 350–366. Springer, Cham, Bamberg, Germany (Sep 2015) 
16. Haider, S.I., Johnell, K., Weitoft, G.R., Thorslund, M., Fastbom, J.: The influence of educa-
tional level on polypharmacy and inappropriate drug use: a register-based study of more 
than 600,000 older people. J. Am. Geriatr. Soc. 57(1), 62–69 (Jan 2009) 
17. Harada, S., Sato, D., Takagi, H., Asakawa, C.: Characteristics of elderly user behavior on 
mobile multi-touch devices. In: Kotze, P., Marsden, G., Lindgaard, G., Wesson, J., Winck-
ler, M. (eds.) Human-Computer Interaction – INTERACT 2013. vol. 8120 LNCS, pp. 323–
341. Springer, Berlin, Heidelberg, Cape Town, South Africa (Sep 2013) 
20 De Croon et al. 
18. Hasher, L.: Zacks, & may, CP (1999). inhibitory control, circadian arousal, and age. Atten-
tion and performance XVII. Cognitive regulation of performance: Interaction of theory and 
application pp. 653–675 
19. Hugtenburg, J.G., Timmers, L., Elders, P.J., Vervloet, M., van Dijk, L.: Definitions, variants, 
and causes of nonadherence with medication: a challenge for tailored interventions. Patient 
Prefer. Adherence 7, 675–682 (Jul 2013) 
20. Ikea: Concept kitchen 2025. http://conceptkitchen2025.ideo.london/, accessed: 2017-5-5 
21. Jimmy, B., Jose, J.: Patient medication adherence: measures in daily practice. Oman Med. 
J. 26(3), 155–159 (May 2011) 
22. Jones, B., Sodhi, R., Murdock, M., Mehra, R., Benko, H., Wilson, A., Ofek, E., MacIntyre, 
B., Raghuvanshi, N., Shapira, L.: RoomAlive: magical experiences enabled by scalable, 
adaptive projector-camera units. In: Proceedings of the 27th annual ACM symposium on 
User interface software and technology. pp. 637–644. ACM, Honolulu, Hawaii, USA (Oct 
2014) 
23. Katz, M.G., Kripalani, S., Weiss, B.D.: Use of pictorial aids in medication instructions: a 
review of the literature. Am. J. Health. Syst. Pharm. 63(23), 2391– 2397 (Dec 2006) 
24. Kientz, J.A., Goodwin, M.S., Hayes, G.R., Abowd, G.D.: Interactive technologies for au-
tism. Synthesis Lectures on Assistive, Rehabilitative, and Health-Preserving Technologies 
2(2), 1–177 (2013) 
25. Kobayashi, L.C., Wardle, J., Wolf, M.S., Wagner, C.: Aging and functional health literacy: 
A systematic review and Meta-Analysis. J. Gerontol. B Psychol. Sci. Soc. Sci. 71(3), 10–
1093 (2014) 
26. Kobayashi, M., Hiyama, A., Miura, T., Asakawa, C., Hirose, M., Ifukube, T.: Elderly user 
evaluation of mobile touchscreen interactions. In: Human-Computer Interaction – 
INTERACT 2011. vol. 6946 LNCS, pp. 83–99. Springer, Berlin, Heidelberg (Sep 2011) 
27. Kripalani, S., Yao, X., Haynes, R.B.: Interventions to enhance medication adherence in 
chronic medical conditions: a systematic review. Arch. Intern. Med. 167(6), 540–550 (Mar 
2007) 
28. Labbé, M.: Find-Object. \url{http://introlab.github.io/find-object} (2011)  
29. Lee, M.L., Dey, A.K.: Real-time feedback for improving medication taking. In: Proceedings 
of the 32Nd Annual ACM Conference on Human Factors in Computing Systems. pp. 2259–
2268. CHI ’14, ACM, New York, NY, USA (2014) 
30. Liu, F., Abdul-Hussain, S., Mahboob, S., Rai, V., Kostrzewski, A.: How useful are medica-
tion patient information leaflets to older adults? a content, readability and layout analysis. 
Int. J. Clin. Pharm. 36(4), 827–834 (Aug 2014) 
31. MacLaughlin, E.J., Raehl, C.L., Treadway, A.K., Sterling, T.L., Zoller, D.P., Bond, C.A.: 
Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs 
Aging 22(3), 231–255 (2005) 
32. Montamat, S.C., Cusack, B.: Overcoming problems with polypharmacy and drug misuse in 
the elderly. Clin. Geriatr. Med. 8(1), 143–158 (Feb 1992) 
33. Ng, A.W.Y., Chan, A.H.S., Ho, V.W.S.: Comprehension by older people of medication in-
formation with or without supplementary pharmaceutical pictograms. Appl. Ergon. 58, 167–
175 (Jan 2017) 
34. Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Ag-
oritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R.A., 
Jedraszewski, D., Cotoi, C., Haynes, R.B.: Interventions for enhancing medication adher-
ence. Cochrane Database Syst. Rev. (11), CD000011 (Nov 2014) 
 MeViTa: Visualizations to Help Older Adults with their Medication 21 
35. O’Leary, P., Carroll, N., Richardson, I.: The practitioner’s perspective on clinical pathway 
support systems. In: 2014 IEEE International Conference on Healthcare Informatics. pp. 
194–201. IEEE, Verona, Italy (2014) 
36. Rothman, A.J., Kiviniemi, M.T.: Treating people with information: an analysis and review 
of approaches to communicating health risk information. J. Natl. Cancer Inst. Monogr. Mon-
ograph(25), 44–51 (1999) 
37. Sauro, J.: A Practical Guide to the System Usability Scale: Background, Benchmarks & Best 
Practices. CreateSpace Independent Publishing Platform, North Charleston SC, United 
States (2011) 
38. Schüz, B., Marx, C., Wurm, S., Warner, L.M., Ziegelmann, J.P., Schwarzer, R., Tesch-
Römer, C.: Medication beliefs predict medication adherence in older adults with multiple 
illnesses. J. Psychosom. Res. 70(2), 179–187 (Feb 2011) 
39. Shneiderman, B.: The eyes have it: a task by data type taxonomy for information visualiza-
tions. In: Proceedings 1996 IEEE Symposium on Visual Languages. pp. 336–343. IEEE 
Comput. Soc. Press, Boulder, Colorado, USA (Sep 1996)  
40. Siek, K.A., Khan, D.U., Ross, S.E., Haverhals, L.M., Meyers, J., Cali, S.R.: Designing a 
personal health application for older adults to manage medications: a comprehensive case 
study. J. Med. Syst. 35(5), 1099–1121 (Oct 2011) 
41. Slone Epidemiology Center: Patterns of medication use in the united states 2006. Tech. rep., 
Epidemiology Center at Boston University, Boston (2006) 
42. Sonne, T., Müller, J., Marshall, P., Obel, C., Grønbæk, K.: Changing family practices with 
assistive technology: MOBERO improves morning and bedtime routines for children with 
ADHD. In: Proceedings of the 2016 CHI Conference on Human Factors in Computing Sys-
tems. pp. 152–164. ACM, New York, New York, USA (May 2016) 
43. Spiegelhalter, D., Pearson, M., Short, I.: Visualizing uncertainty about the future. Science 
333(6048), 1393–1400 (Sep 2011) 
44. Tanuwidjaja, E., Huynh, D., Koa, K., Nguyen, C., Shao, C., Torbett, P., Emmenegger, C., 
Weibel, N.: Chroma: A wearable augmented-reality solution for color blindness. In: Pro-
ceedings of the 2014 ACM International Joint Conference on Pervasive and Ubiquitous 
Computing. pp. 799–810. UbiComp ’14, ACM, New York, NY, USA (2014) 
45. The Regents of the University of Michigan and the Robert Wood Johnson Foundation: Vis-
ualizing health. http://www.vizhealth.org/, accessed: 2017-5-5 
46. Ullmer, B., Ishii, H.: The metaDESK: Models and prototypes for tangible user interfaces. 
In: Proceedings of the 10th Annual ACM Symposium on User Interface Software and Tech-
nology. pp. 223–232. UIST ’97, ACM, New York, NY, USA(1997) 
47. vitalink: Medicatiegegevens delen. http://www.vitalink.be/ medicatiegegevens-delen, ac-
cessed: 2017-5-5 
48. Waycott, J., Vetere, F., Pedell, S., Morgans, A., Ozanne, E., Kulik, L.: Not for me: Older 
adults choosing not to participate in a social isolation intervention. In: Proceedings of the 
2016 CHI Conference on Human Factors in Computing Systems. pp. 745–757. CHI ’16, 
ACM, New York, NY, USA (2016) 
49. Wilson, A.D., Benko, H.: Combining multiple depth cameras and projectors for interactions 
on, above and between surfaces. In: Proceedings of the 23nd annual ACM symposium on 
User interface software and technology. pp. 273–282. ACM, New York, New York, USA 
(Oct 2010) 
50. Wrede-Sach, J., Voigt, I., Diederichs-Egidi, H., Hummers-Pradier, E., Dierks, M.L., Junius-
Walker, U.: Decision-making of older patients in context of the doctorpatient relationship: 
a typology ranging from “self-determined” to “doctor-trusting” patients. Int. J. Family Med. 
2013, 478498 (Apr 2013) 
22 De Croon et al. 
51. Yamamoto, G., Hyry, J., Krichenbauer, M., Taketomi, T., Sandor, C., Kato, H., Pulli, P.: A 
user interface design for the elderly using a projection tabletop system. In: 2015 3rd IEEE 
VR International Workshop on Virtual and Augmented Assistive Technology (VAAT). vol. 
51, pp. 29–32. IEEE (Mar 2015) 
